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The laminin α2 expressed by dystrophic dy2J mice is defective in
its ability to form polymers
Holly Colognato and Peter D. Yurchenco
Mutations in LAMA2 cause severe congenital muscular
dystrophy accompanied by nervous system defects [1].
Mice homozygous for the dy2J allele of LAMA2 express
a laminin α2 subunit that has a deletion in the amino-
terminal domain VI, providing an animal model for
study of the molecular basis of congenital muscular
dystrophy [2,3]. Domain VI is predicted to be involved
in laminin polymerization, along with amino-terminal
domains from laminin β and γ chains [4]. In a solution-
polymerization assay, we found that purified dy2J
laminin assembled poorly and formed little polymer,
in contrast to wild-type muscle laminin. Furthermore,
dissolution of the collagen IV network caused dy2J
laminin to be released into solution, indicating that
laminin polymers within the skeletal muscle basement
membrane were defective. In addition to loss of
polymerization, dy2J laminin had a reduced affinity for
heparin. Finally, recombinant laminin engineered with
the dy2J deletion was more sensitive to proteolysis and
was readily cleaved near the junction of domains V and
VI. Thus, the dy2J deletion selectively disrupts polymer
formation, reduces affinity for heparin, and destabilizes
domain VI. These are the first specific functional
defects to be identified in a muscular dystrophy laminin,
and it is likely that these defects contribute to the
abnormalities seen in dy2J/dy2J muscle and nerve.
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Results and discussion
Mice homozygous for the dy2J allele of LAMA2 express a
laminin α2 subunit that has a 57 amino acid deletion and a
Gln91Glu substitution within domain VI [2,3]. The dy2J
laminin α2 subunit was reported to have an apparent mol-
ecular mass that, depending on the tissue, ranged from
10–55 kDa smaller than normal, which is seemingly at
odds with a 57 amino acid deletion [2,3]. To further inves-
tigate this discrepancy, we engineered a recombinant
amino-terminal fragment of laminin α2 that had the same
deletion as in the dy2J allele, α2(VI–IVb)∆dy2J. This was
compared with dy2J α2 from skeletal muscle and with a
fragment without the deletion, α2(VI–IVb). Laminin-2/4,
a mixture of laminin-2 (α2β1γ1) and laminin-4 (α2β2γ1),
was extracted from wild-type and dy2J/dy2J skeletal muscle
and analyzed by SDS–PAGE (Figure 1a). The laminin α2
subunit had an apparent molecular weight of ~300 kDa,
whereas the dy2J α2 subunit was 25–30 kDa smaller. The
engineered fragment α2(VI–IVb)∆dy2J had an apparent
molecular weight that was only 6 kDa smaller than that of
α2(VI–IVb), however, a size difference more consistent
with the removal of 57 amino acids (Figure 1c, zero time
points). We also noted a faster-migrating band (~100 kDa)
in some of our preparations of α2(VI–IVb)∆dy2J, which is
likely to be a degradation product as it reacted with α2-
specific antibodies (data not shown). 
We compared the stability of α2(VI–IVb) and α2(VI–IVb)∆dy2J
using limited proteolysis and found that the mutant protein
was cleaved by elastase at approximately 50 times the rate
of wild-type protein (Figure 1c). Furthermore, proteolysis
resulted in a truncated protein with an apparent molecular
weight of ~98 kDa. The truncated protein was sequenced
from its amino terminus and found to have the sequence
XVK(X/D)ISVGXM (in the single-letter amino acid code,
where X is an unknown amino acid). This sequence corre-
sponds to the last nine residues of domain VI, so the amino
terminus of the truncated protein lies nine residues
upstream from the predicted junction of domains VI and V
[5]. These data suggest that the deletion destabilizes
domain VI and exposes a proteolytically sensitive region
just upstream of the junction of domains VI and V
(Figure 1d). We propose that the mutant domain VI is
unstable and is easily truncated in vivo, accounting for the
apparent difference from the wild-type molecular weight of
25–30 kDa that was consistent in all preparations of
dy2J/dy2J skeletal muscle. Other tissues of dy2J/dy2J mice are
reported to show distinct, yet consistent, changes in the
molecular weight of laminin α2 [3], so the degree of trunca-
tion that occurs in vivo may depend upon tissue-specific
factors such as the local complement of proteases or post-
translational modifications. 
Several lines of evidence suggest that expression of dy2J
laminin leads to muscle pathology through a misregula-
tion of basement membrane architecture rather than
through loss of binding sites for laminin receptors. First,
dy2J/dy2J sarcolemmal basement membranes appear
abnormal, but do not appear to have a large reduction in
laminin α2. Immunofluorescence studies suggest that the
amount of laminin α2 in dy2J/dy2J muscle is not signifi-
cantly different than normal [2,3]. Using the ratio of
myosin mass to total mass as a corrective factor for fibro-
sis, we consistently observed levels of laminin α2 that
were ~70% of those in normal mice (data not shown).
Second, the principal receptors for α2 laminins in mature
skeletal muscle are thought to be α7β1 integrin and dys-
troglycan, both of which bind exclusively to the carboxy-
terminal region of laminin-2/4 [6,7]. Direct binding was
not detected between α2(VI–IVb) and myotubes and
addition of laminin carboxy-terminal fragments to
myotubes completely prevented binding of laminin-2/4
[8]. Finally, laminins-2 and -4 are known to form a three-
dimensional, mesh-like polymer proposed to be mediated
by interactions among the amino-terminal short arms of
its α, β, and γ subunits [9,10].
We observed differences in the solubility of laminin-2/4
isolated from the skeletal muscle of wild type and
dy2J/dy2J mice. Collagenase was used to disrupt the type
IV collagen network, which can link to the laminin
network through interactions with entactin/nidogen [11].
Subsequent EDTA treatment was used to dissociate the
calcium-dependent laminin polymer [12] and to disrupt
laminin–receptor interactions. A large fraction (nearly
50%) of laminin-2/4 was released into solution from
dy2J/dy2J skeletal muscle following collagenase treatment,
whereas the majority of laminin-2/4 from wild-type skele-
tal muscle required additional treatment with EDTA to
be solubilized (Figure 2a,b). This difference in solubility
indicated that dy2J laminin was primarily associated with
the basement membrane through surviving non-polymer
bonds, such as linkage to the collagen IV network through
entactin/nidogen. We next evaluated dy2J laminin-2/4
purified from skeletal muscle in a copolymerization assay,
which could detect the polymerization capacity of small
quantities of protein [10]. Laminin-2/4 from wild-type
skeletal muscle increasingly sedimented with the polymer
fraction as total laminin concentration increased, whereas
the majority of laminin-2/4 from dy2J/dy2J mice remained
in the soluble pool (Figure 2c–e). Thus, laminin-2/4
expressed by dy2J/dy2J mice is defective in its ability to
form a laminin polymer. 
Next, the ability of dy2J laminin-2/4 to bind heparin was
evaluated. Using high performance liquid chromatogra-
phy (HPLC) heparin-affinity chromatography, we com-
pared the elution positions of laminin-2/4 from normal
and dy2J/dy2J mice (Figure 3). Although dy2J laminin-2/4
bound heparin, it eluted at a lower salt concentration than
normal laminin-2/4. Both proteins contain a heparin-
binding region in the carboxy-terminal G domain that is
known to mediate interactions with dystroglycan, a mol-
ecule that links the dystrophin–glycoprotein complex and
the extracellular matrix [6,7]. This site is unaffected in
dy2J/dy2J mice, so the difference in relative heparin affinity
must reflect changes in the second heparin-binding site,
mapped to domain VI [13]. Basic amino acids arginine and
lysine are thought to be essential for mediating electrosta-
tic interactions with the negatively charged sulfate and
carboxylic acid groups of heparin [14]. If a charge of +1 is
assigned to arginine and lysine and –1 to aspartic acid and
glutamic acid, wild-type domain VI has a net positive
charge of +2 and dy2J domain VI has a net loss of basic
residues that reduces the net charge to zero. Furthermore,
two N-glycosylation consensus sites are deleted in dy2J
α2, which may contribute to changes in heparin binding
as well as to decreased stability. It is possible that the loss
of these positively charged residues disrupts a crucial
interaction with molecules containing negatively charged
groups such as heparan sulfate or polysialic acid, but an in
vivo role for the heparin binding site in domain VI has yet
to be established. 
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Figure 1
Limited proteolysis of wild-type and dystrophic α2(VI–IVb) shows that
the dy2J domain VI is more sensitive to proteolysis and is truncated.
(a) SDS–PAGE under reducing conditions of laminin-2/4 extracted
from wild-type (+/+) and dy2J/dy2J mice. Laminins were isolated using
collagenase, EDTA, and heparin-affinity chromatography. The laminin
α2 chain migrates faster; its apparent molecular mass is ~25 kDa less
than that of wild-type α2 (300 vs 275 kDa). (b) Schematic
representation of the α2(VI–IVb)∆dy2J engineered laminin fragment.
The amino-terminal region of the laminin α2 chain has a 57 amino acid
deletion and Gln91Glu substitution (arrow) within domain VI.
(c) Fragments α2(VI–IVb) and α2(VI–IVb)∆dy2J were found to migrate
with relative molecular masses of 122 kDa and 116 kDa, respectively, a
difference of ~6 kDa (see zero time points). Protein fragments were
digested with elastase for the indicated times at 25°C
(enzyme:substrate ratio 1:50) and evaluated under reducing conditions.
The α2(VI–IVb) fragment was fairly resistant to elastase over time,
whereas α2(VI–IVb)∆dy2J was readily degraded to a smaller apparent
molecular mass of 98 kDa (~24 kDa smaller than α2(VI–IVb)). Amino-
terminal sequencing of the 98 kDa fragment (data not shown) indicated
that domain VI was completely removed, with the exception of nine
amino acids. (d) Model of the probable reason for the much smaller
molecular weight of dy2J/dy2J laminin than predicted from its structure.
Deletion of 57 amino acids in domain VI exposes a proteolytically
sensitive region just upstream of the junction with domain V. Proteolysis
therefore leads to degradation of nearly all of domain VI.
α2
+/+
VI V IVb IIIb
VI
V
IVb IVb
Current Biology   
V
Protease
122
Time (min) 0 5 10 20 40 18090 0 5 10 20 40 18090
(a) (b)
(c)
(d)
β1
γ1
β2
116
98
dy2J
dy2J
α2(VI–VIb) α2(VI–VIb)dy2J
Laminin polymerization may be important for maintain-
ing the structural integrity of the basement membrane,
given the alterations seen in dy2J/dy2J mice. Several
factors suggest this may not be the only role for laminin
polymerization, however. For instance, the collagen IV
network assembles through interactions of considerably
higher affinity than laminin self-assembly interactions.
Although the collagen IV network is present in the base-
ment membranes of dy2J/dy2J mice, it clearly does not
compensate for the functional deficits in laminin. Fur-
thermore, one might expect a defect caused by structural
weakness to be much more pronounced at points of
attachment like the muscle–tendon junction, but there is
no evidence for such a defect. 
An additional role for laminin polymerization was
described recently, in which polymerization was found to
induce changes in the organization of muscle receptors and
of components of the cortical cytoskeleton such as dys-
trophin and vinculin [8]. In agreement with this hypothe-
sis, the sarcolemmal cortex of dy2J/dy2J skeletal muscle has
a grossly irregular appearance in transmission electron
micrographs (H.C. and P.D.Y., unpublished observations).
Based on the data presented here, an emerging hypothesis
is that laminin polymerization may be required for the
development or maintenance of proper cortical architec-
ture in the muscle sarcolemma (Figure 4). It is also realistic
to assume that architectural changes propagated from
basement membrane to cytoskeleton may have profound
signaling consequences, as has been found for fibronectin
fibrillogenesis [15–18]. The differential ability of various
laminins to polymerize may represent a normal regulatory
mechanism by which different laminins transmit different
signals using common receptors.
As well as the muscle defect, dy2J/dy2J mice have poorly
myelinated axons. Evaluation of this defect may prove to
be more complex. In contrast to skeletal muscle, evidence
suggests that Schwann cell receptors interact with domain
VI of laminin α2. Schwann cells express high levels of the
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Figure 2
Polymerization of laminin-2/4 from wild type (+/+) and dy2J/dy2J mice.
(a,b) Mouse skeletal muscle was treated with bacterial collagenase
(Coll) followed by 10 mM EDTA. (a) Solubilized protein was evaluated
using SDS–PAGE and immunoblotted with an antibody against
laminin α2 chain [20]. (b) The percentage of total protein released
into solution at each step, determined by densitometry, is shown.
(c,d) Copolymerization of laminin-2/4 from (c) wild-type and
(d) dy2J/dy2J mice. Laminin polymer formation was evaluated in a
sedimentation assay in which the degree of polymer formation has been
found to be independent of the concentration of test laminin [10].
Briefly, fixed amounts of laminin-2/4 extracted from skeletal muscle (test
laminin) were added to aliquots containing various concentrations of
laminin-1 (Lm-1) and incubated at 37°C for 3 h. Differential
centrifugation was used to pellet the laminin polymer, and unpolymerized
laminin remained in solution. Immunoblots of supernatant (S) and
polymer (P) fractions were probed with an antibody that recognizes the
laminin α2 subunit. Bands were visualized using a DuraSuperSignal
chemiluminescence detection kit (Pierce) and quantitated by
PhosphoAnalysis (BioRad). Wild-type laminin-2/4 copolymerized with
laminin-1 and at higher laminin-1 concentrations was increasingly found
in the polymer fraction, whereas dy2J/dy2J laminin-2/4 remained largely
in the supernatant fraction. (e) Graph of the fraction of laminin α2
subunit that appeared as polymer versus total laminin concentration.
Filled circles, wild-type laminin-2/4; open circles, dy2J/dy2J laminin-2/4.
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Figure 3
Heparin binding to dy2J/dy2J laminin-2. Laminin-2/4 extracted from
either wild-type (+/+) or dy2J/dy2J mice was applied to a HPLC
heparin-affinity column in 50 mM Tris pH 8.0 and 0.5 mM EDTA.
Bound protein was eluted using a 0–1.0 M linear NaCl gradient. Both
proteins bound to the heparin column, but dy2J laminin-2/4 eluted at a
lower salt concentration, reflecting a lower affinity for heparin. Solid
lines, protein concentrations; dotted line, NaCl concentration.
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α1β1 integrin [19], an integrin that interacts with domain
VI of the laminin α2 chain [13]. Preliminary data suggest
that interactions between primary Schwann cells and the
amino-terminal region of laminin α2 may in part be medi-
ated by additional receptor(s) (H.C. and P.D.Y., unpub-
lished observations). Because of its heparin-binding
characteristics, domain VI is also a good candidate to inter-
act with negatively charged groups like sulfated gly-
cosaminoglycan chains or polysialic acid. As sulfated
proteoglycans and polysialic acid epitopes are highly
expressed in the central nervous system, the brain abnor-
malities seen in many LAMA2 congenital muscular dys-
trophies may involve loss of such interactions. 
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Figure 4
Model depicting laminin polymerization in the muscle sarcolemmal
basement membrane. (a) Wild-type laminin normally interacts with
other laminin molecules to form a polymer. Laminin polymerization on
the muscle cell surface can induce reorganization of receptors and
cytoskeletal components [8] that may provide a needed signal for
muscle stability or regeneration. (b) Dystrophic dy2J laminin is
defective in polymer formation and therefore cannot induce the
polymerization-dependent changes in cell architecture that may play a
role in muscle survival.
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